Amphastar Pharmaceuticals, Inc. (AMPH)
After hours:
| Previous Close | 42.21 |
| Open | 42.30 |
| Bid | 42.21 x 100 |
| Ask | 42.51 x 100 |
| Day's Range | 41.24 - 42.50 |
| 52 Week Range | 38.43 - 67.66 |
| Volume | |
| Avg. Volume | 418,104 |
| Market Cap | 2.072B |
| Beta (5Y Monthly) | 0.85 |
| PE Ratio (TTM) | 14.56 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- ACCESSWIRE
Amphastar Pharmaceuticals to Present at the Bank of America Securities Health Care Conference
RANCHO CUCAMONGA, CA / ACCESSWIRE / May 9, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, and Dan Dischner SVP of Corp. Communication, will participate in an Analyst-Moderated fireside chat at the Bank ...
- ACCESSWIRE
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2024
Reports Net Revenues of $171.8 Million for the Three Months Ended March 31, 2024 RANCHO CUCAMONGA, CA / ACCESSWIRE / May 8, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") today reported results for the three months ...
- ACCESSWIRE
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 8, 2024
RANCHO CUCAMONGA, CA / ACCESSWIRE / April 30, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its first quarter of 2024 ended March 31, 2024, after the market closes on Wednesday, May 8, 2024, ...
